2023/0671 - RISDIPLAM [60 MG PÓ SOL ORAL FRS]
TED · 377188-2026Award noticeawardedNo deadline given
Value
Estimated€199,801 · 199,800.81 EUR
Awarded—
WinnerROCHE Farmacêutica Química, LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 21 | — | 2026-08-04 |
| GILEAD SCIENCES, LDA | 18 | — | 2026-07-28 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 15 | €1,569,649 | 2026-08-04 |
| NOVARTIS FARMA - PROD.FARM SA | 11 | — | 2026-08-04 |
| JANSSEN-CILAG FARMACEUTICA LDA | 9 | €371,730 | 2026-08-04 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
RISDIPLAM [60 MG PÓ SOL ORAL FRS]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-02 | 2023/0671 - RISDIPLAM [60 MG PÓ SOL ORAL FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-08-04 | 2026/0002 - RISDIPLAM [60 MG PÓ SOL ORAL FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 98% |
| 2026-05-12 | 2023/0671 - PATISIRAN [2 MG/ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-06-30 | 2023/0491 - RUXOLITINIB [5 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-06-24 | 2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-06-24 | 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |